Search results
Cucumber recall update as FDA sets highest risk level
Newsweek· 2 days agoA range of recalled whole cucumbers have been designated a Class I risk level by the U.S. Food and...
FDA approves MSD’s KEYTRUDA for advanced endometrial cancer
Pharmaceutical Technology via Yahoo Finance· 53 minutes agoThe US Food and Drug Administration (FDA) has approved MSD’s anti-PD-1 therapy KEYTRUDA for use with...
FDA took 15 months to act on infant formula whistleblower complaint, audit says
The Hill via Yahoo News· 13 hours agoThe Food and Drug Administration (FDA) was dangerously slow to respond to multiple complaints about...
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 17 hours agoNovavax (NVAX) seeks FDA???s approval to update its COVID-19 vaccine for the 2024-2025 fall season...
Gateway - The Root
The Root· 21 minutes agoThe legislation, introduced by Rep. Rosa DeLauro (D-CT), chair of the House Appropriations Committee, would give the FDA $28 million in emergency funding for additional inspectors ...
Coronavirus company news summary – US FDA authorises LetsGetChecked’s home collection Covid-19 test...
Medical Device Network via Yahoo Finance· 4 hours agoFDA Authorization of Let’sGetChecked’s Home Collection COVID-19 Test LetsGetChecked has announced that the US Food and Drug Administration (FDA) has authorised ...
FDA Expands Pembrolizumab Approval for Endometrial Cancer
Medscape· 4 hours agoThe FDA expanded the approval of pembrolizumab based on improved PFS in patients with advanced or recurrent endometrial cancer in a randomized phase 3 trial.
More people sent to hospital as mushroom-infused 'microdosing' chocolate faces ongoing FDA probe
Fox News· 1 day ago"Microdosing" chocolate bars designed to give consumers "peace of mind" have sent more and more...
Milestone for Biotest: US Approval for Innovative Immunoglobulin Yimmugo
NewMediaWire via Yahoo Finance· 14 hours agoFDA approval secures significant future sales and earnings growth through entry into the world's...
FDA official: The risk of secondary cancer from CAR-T therapy is less than feared
Medical Xpress· 19 hours agoThe risk of secondary cancer after CAR-T therapy, pioneered at Penn, is less than regulators feared...
